MedImmune Files Investigational New Drug Application for MT103
August 21, 2006 03:28 ET
|
Micromet Inc.
GAITHERSBURG, Md. and CARLSBAD, Calif., Aug. 21, 2006 (PRIMEZONE) -- MedImmune, Inc. (Nasdaq:MEDI) and Micromet, Inc. (Nasdaq:MITI) today announced that MedImmune has filed an investigational new drug...